A histological cohort study fo assess the adverse events using Adspray in laparoscopic surgery for early uterine endometrial cancer.

A histological cohort study fo assess the adverse events using Adspray in laparoscopic surgery for early uterine endometrial cancer. - Adieu study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041628

Enrollment

300

Registered

2020-09-01

Start date

2020-06-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine endometrial cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Patients with presumed advanced stage classification (FIGO2008) stage IA endometrial cancer who scheduled for laparoscopic hysterectomy including pelvic lymph node dissection (not including para-aortic lymph node dissection. robot-assisted surgery using da Vinci surgical system is acceptable). 2. Patients planning to use Adspray 3. ECOG performance Status 0 or 1. 4. Informed written consent is obtained.

Exclusion criteria

Exclusion criteria: 1. Patients scheduled for laparotomy. 2. Patients scheduled for surgery without pelvic lymph node dissection. 3. Patients scheduled for para-aortic lymph node dissection. 4. Patients with pelvic infection or infectious diseases requiring treatment. 5. History of obstructive bowel disease. 6. History of pelvic radiation therapy. 7. Patients who are judged to be inappropriate as subject to this study by the physician.

Design outcomes

Primary

Measure	Time frame
Incidence of postoperative infection within 30 days after surgery	—

Countries

Japan

Contacts

Public ContactTakashi Motohashi

Tokyo Women's Medical University Gynecology

sr21det@rb3.so-net.ne.jp03-3353-8111

Outcome results